Dhavalkumar Patel has joined the board of directors at Inflazome, the Irish-owned biotech company developing small molecule drugs to treat inflammation, as an independet director. Patel is executive vice-president and chief scientific officer at Belgian-headquartered biopharma company UCB. He joined UCB in 2016, having been head of the Novartis Institute for Biomedical Research in Europe for six years.
Inflazome has also made two appointments to its scientific advisory board. Frances Balkwill joins from Queen Mary University...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team